Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1989 1
1991 2
1992 2
1993 1
1994 2
1996 2
1997 1
1998 4
1999 5
2000 5
2001 2
2002 10
2003 9
2004 4
2005 13
2006 8
2007 8
2008 13
2009 15
2010 14
2011 14
2012 21
2013 14
2014 11
2015 10
2016 9
2017 7
2018 13
2019 8
2020 7
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

206 results
Results by year
Filters applied: . Clear all
Page 1
N-Acylhydrazones as drugs.
Thota S, Rodrigues DA, Pinheiro PSM, Lima LM, Fraga CAM, Barreiro EJ. Thota S, et al. Among authors: barreiro ej. Bioorg Med Chem Lett. 2018 Sep 15;28(17):2797-2806. doi: 10.1016/j.bmcl.2018.07.015. Epub 2018 Jul 9. Bioorg Med Chem Lett. 2018. PMID: 30006065 Review.
Chemical Intuition in Drug Design and Discovery.
Pedreira JGB, Franco LS, Barreiro EJ. Pedreira JGB, et al. Among authors: barreiro ej. Curr Top Med Chem. 2019;19(19):1679-1693. doi: 10.2174/1568026619666190620144142. Curr Top Med Chem. 2019. PMID: 31258088 Review.
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Thota S, Rodrigues DA, Crans DC, Barreiro EJ. Thota S, et al. Among authors: barreiro ej. J Med Chem. 2018 Jul 26;61(14):5805-5821. doi: 10.1021/acs.jmedchem.7b01689. Epub 2018 Feb 26. J Med Chem. 2018. PMID: 29446940 Review.
Novel VEGFR-2 inhibitors with an N-acylhydrazone scaffold.
Pauli FP, Martins JR, Paschoalin T, Ionta M, Barbosa MLC, Barreiro EJ. Pauli FP, et al. Among authors: barreiro ej. Arch Pharm (Weinheim). 2020 Nov;353(11):e2000130. doi: 10.1002/ardp.202000130. Epub 2020 Jul 15. Arch Pharm (Weinheim). 2020. PMID: 32667721
206 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page